Genovis AB - Strategy, SWOT and Corporate Finance Report

Genovis AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company

Key Highlights

Genovis AB (Genovis) develops, produces and markets enzyme products, which facilitate the development and quality control of biological drugs. The company’s products are used for antibody molecules analysis to identify and characterize proteins, antibody based biotherapeutics; monoclonal antibodies, antibody drug conjugates and biosimilars. Its SmartEnzymes product portfolio encompasses Fabricator (IdeS), Gingiskhan (KGP), Fabulous (SpeB), Glycinator (EndoS49), Fabricator Z (IdeZ), Gingisrex (Rgp) and IgGzero (EndoS). Genovis also offers antibody fragmentation services for different species and subclasses of Immunoglobulin G antibodies. The company offers its products to medical device, pharmaceutical and biotechnology sectors as well as contract manufacturing companies. It has presence in Massachusetts, the US; Europe and other countries. Genovis is headquartered in Lund, Sweden.

Scope

  • Detailed information on Genovis AB required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting Genovis AB in the form of a SWOT analysis
  • An in-depth view of the business model of Genovis AB including a breakdown and examination of key business segments
  • News about Genovis AB, such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

  • Gain understanding of Genovis AB and the factors that influence its strategies.
  • Track strategic initiatives of the company and latest corporate news and actions.
  • Assess Genovis AB as a prospective partner, vendor or supplier.
  • Support sales activities by understanding your customers' businesses better.
  • Stay up to date on Genovis ABs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Thermo Fisher Scientific Inc

ProZyme Inc

New England Biolabs Inc

GE Healthcare AB

Bio-Rad Laboratories Inc

Thermo Fisher Scientific Inc

ProZyme Inc

New England Biolabs Inc

GE Healthcare AB

Bio-Rad Laboratories Inc

Table of Contents

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Genovis AB - Key Facts

Genovis AB ...

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Genovis AB - Key Facts

Genovis AB - Key Employees

Genovis AB - Key Employee Biographies

Genovis AB - Major Products and Services

Genovis AB - History

Genovis AB - Company Statement

Genovis AB - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

Genovis AB - Business Description

Genovis AB - Corporate Strategy

Genovis AB - SWOT Analysis

SWOT Analysis - Overview

Genovis AB - Strengths

Genovis AB - Weaknesses

Genovis AB - Opportunities

Genovis AB - Threats

Genovis AB - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Genovis AB, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Genovis AB, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Genovis AB, Recent Deals Summary

Section 5 – Company’s Recent Developments

Aug 28, 2019: GENOVIS: Half-Yearly Report January – June 2019

Aug 19, 2019: Genovis receives order worth about SEK 13 million

Jun 19, 2019: Genovis hires CFO

May 28, 2019: Genovis launches SialEXO 23 to enhance glycan research

May 16, 2019: Genovis signs distribution agreement with FUJIFILM Wako Pure Chemical for Japan, Taiwan and Singapore markets

May 08, 2019: Genovis: Interim report January – March 2019

Apr 08, 2019: Thermo Fisher Scientific announces collaboration to advance biopharmaceutical characterization and monitoring methods

Apr 08, 2019: Genovis and Thermo Fisher Scientific announces collaboration to advance biopharmaceutical characterization and monitoring workflows

Nov 27, 2018: Genovis: Interim report January – September 2018

Nov 08, 2018: Genovis certified to ISO 9001:2015

Section 6 – Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer

List of Tables

List of Tables

Genovis AB, Key Facts

Genovis AB, Key Employees

Genovis AB, Key Employee Biographies

Genovis AB, Major Products and Services

Genovis AB, History ...

List of Tables

Genovis AB, Key Facts

Genovis AB, Key Employees

Genovis AB, Key Employee Biographies

Genovis AB, Major Products and Services

Genovis AB, History

Genovis AB, Subsidiaries

Genovis AB, Key Competitors

Genovis AB, Ratios based on current share price

Genovis AB, Annual Ratios

Genovis AB, Annual Ratios (Cont...1)

Genovis AB, Interim Ratios

Genovis AB, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Genovis AB, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Genovis AB, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Genovis AB, Performance Chart (2014 - 2018)

Genovis AB, Ratio Charts

Genovis AB, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD ...

List of Figures

Genovis AB, Performance Chart (2014 - 2018)

Genovis AB, Ratio Charts

Genovis AB, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Genovis AB, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports